Agoracom Blog Home

Posts Tagged ‘CSE’

Avicanna Inc. $AVCN.ca to Host Second Quarter 2020 Investor Conference Call $CRDL.ca $PCLO.ca $WEED.ca $ACB.ca

Posted by AGORACOM-JC at 6:46 PM on Friday, August 7th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

TORONTO, Aug. 7, 2020 – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that it has scheduled a conference call on Monday, August 17, 2020 at 9:00AM Eastern Time to discuss the results for its fiscal second quarter ended June 30, 2020. Aras Azadian, Chief Executive Officer and Davender Sohi, Chief Financial Officer, will host the call and a question and answer period. The Company will report its financial results for the second quarter after the close of markets on Friday, August 14, 2020.

            Conference Call Details

DATE:                                           August 17, 2020                                   
TIME:  9:00 AM Eastern Time
  
CONFIRMATION #:                             64751998
  
TORONTO:                                           416-764-8659
NORTH AMERICAN TOLL FREE:         1-888-664-6392
GERMANY TOLL FREE:   08007240293
COLOMBIA TOLL FREE:      018005184036
  
REPLAY TORONTO:                             416-764-8677  
REPLAY NORTH AMERICA:    1-888-390-0541 
REPLAY ENTRY CODE:   751998#
REPLAY EXPIRATION DATE:               August 24, 2020

About Avicanna Inc.

Avicanna is an Ontario, Canada based corporation focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.

Avicanna’s two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna’s cultivation activities. These two companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including cannabidiol (CBD) and tetrahydrocannabinol (THC).

Avicanna’s research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna’s scientific team develops products, and Avicanna has also engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto for the purpose of optimizing and improving upon its products.

Avicanna’s research and development and cultivation activities are focused on the development of its key products, including plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and Extracts (defined as plant-derived cannabinoid extracts and purified cannabinoids, including distillates and isolates), with a goal of eventually having these products manufactured and distributed through various markets.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated April 15, 2020 (the “AIF“) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE Avicanna Inc.

Terry Booth Schedules Investor Conference Call to Discuss Binovi’s $VISN.ca New Direction $EYPT $KALA

Posted by AGORACOM-JC at 4:16 PM on Friday, August 7th, 2020
http://www.smallcapepicenter.com/binovi%20square.png
  • Executive Chairman Terry Booth wishes to set up a special investor conference call to discuss the Company’s new direction
  • The call will be hosted on Tuesday, August 11th, 2020 with Binovi Technologies Executive Chairman, Terry Booth and Adam Cegielski, CEO.

Toronto, New York – August 7, 2020 – Binovi Technologies Corp., (Binovi) (TSXV:VISN) | (OTC:BNVIF) announces that in light of the latest developments, Executive Chairman Terry Booth wishes to set up a special investor conference call to discuss the Company’s new direction. The call will be hosted on Tuesday, August 11th, 2020 with Binovi Technologies Executive Chairman, Terry Booth and Adam Cegielski, CEO.

The call will be held on Tuesday August 11th, at 4:15pm EST (1:15pm PST).

Conference details:

Canada/USA TF: 1-800-319-4610
International Toll: +1-604-638-5340
Germany TF: 0800-180-1954

Callers should dial in 5 – 10 min prior to the scheduled start time and simply ask to join the call.

Conference replay

Canada/USA TF: 1-800-319-6413
International Toll: +1-604-638-9010
Replay Access Code: 5088

For additional information on the Company, please visit https://www.binovi.com/investor-reports/

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 1,500 locations across 20 countries.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Innocan’s $INNO.ca SHIR (TM) Beauty & Science #CBD Derma Cosmetics Products Passed Safety Assessments and Have Been Approved for Marketing in the European Union $GWPH $CRDL.ca $PCLO.ca

Posted by AGORACOM-JC at 4:45 PM on Thursday, August 6th, 2020
Innocan-Blog
  • Announced that its SHIR™ CBD Derma Cosmetic product line, has successfully passed safety assessment in accordance with European Union (EU) cosmetic regulation No 1223/2009 and received a EU Cosmetic Product Safety Report for marketing in the European Union
  • SHIR™ skincare products combine the benefits of CBD with the most effective ingredients in an innovative formula to deliver visible results
  • The SHIR™ Beauty & science products that are approved for marketing in the Europe are: SHIR CBD+ ANTI-AGING Beauty Sleeping Mask ,SHIR CBD MUST Eye Serum, SHIR CBD MUST Recovery Lotion, SHIR CBD MUST Glow Oil, SHIR CBD MUST Face Cream, SHIR CBD+ ANTI-AGING Facial Serum

Herzliya, Israel and Calgary, Alberta–(August 6, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to announce that its SHIR™ CBD Derma Cosmetic product line, has successfully passed safety assessment in accordance with European Union (EU) cosmetic regulation No 1223/2009 and received a EU Cosmetic Product Safety Report for marketing in the European Union.

SHIR™ skincare products combine the benefits of CBD with the most effective ingredients in an innovative formula to deliver visible results. The SHIR™ Beauty & science products that are approved for marketing in the Europe are: SHIR CBD+ ANTI-AGING Beauty Sleeping Mask ,SHIR CBD MUST Eye Serum, SHIR CBD MUST Recovery Lotion, SHIR CBD MUST Glow Oil, SHIR CBD MUST Face Cream, SHIR CBD+ ANTI-AGING Facial Serum.

Innocan’s SHIR™ Beauty & Science CBD Derma Cosmetics

https://orders.newsfilecorp.com/files/6922/61225_6b37fecc040dc9bd_002full.jpg



To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6922/61225_6b37fecc040dc9bd_002full.jpg

“As a Pharma Company, Innocan is committed to creating premium products that meet the highest quality standards to provide consumer confidence,” Iris Bincovich, co-founder and CEO of Innocan states. “Compliance with EU regulation is a major milestone for us, following the receipt of technical validation from the FDA for the marketing in the US of our over-the-counter Relief & Go Pain Relief spray, a few weeks ago. The next step is to initiate our various distribution platforms to deliver our SHIR™ CBD Derma Cosmetic line across the European Union and other markets where legally permitted to do so.”

About Innocan

The Company, through its wholly owned subsidiary, Innocan Pharma Ltd., is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”). Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the COVID-19 Corona Virus using CBD. CBD-Loaded Exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

The Company signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release Liposome to be administrated by Injection. The Company plans, together with Prof. Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University to test the Liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, the effectiveness and safety of the Company’s products, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

VIDEO – ImagineAR $IP.ca $IPNFF Adds Media Powerhouse Michael Anderson To Spearhead UK & Euro Sales $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 4:30 PM on Thursday, August 6th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

If you were a small cap Augmented Reality company from Vancouver that needed to appoint an old media / new media powerhouse to head up your European sales operations, we really don’t think you could have found someone better credentialed than Michael Anderson – and that’s exactly what ImagineAR (IP:CSE) (IPNFF:OTCQB) did.  

Anderson is a highly regarded leader in the world of digital with his roots firmly based in UK media. Part entrepreneur, part corporate animal, he quickly rose through the ranks ending up as Managing Director of News UK. He worked for Rupert Murdoch and Les Hinton during his rise to the top and made the Board room of both News UK and Associated Newspapers (publishers of the Daily Mail).   

Sensing the changing winds of the media business, Anderson was a driving force on the launch team of Metro, which overtook The Sun in 2018 as the largest circulation of any newspaper in the UK.  At Metro, he was instrumental in the paper being cited as a new business case with commercial results not seen previously in the newspaper industry, growing revenue from £100k a week to £1m per week in just 12 months.  Additionally, Mike was the founder of the Chelsea APPS Factory which included UK clients KPMG, Ladbrokes, Standard Life, TfL, Vanquis and Waitrose.    

….. And now he is sensing another change in the winds to put his considerable talents and team behind the Augmented Reality solutions of ImagineAR.  

If you don’t know what Augmented Reality (AR) is, this quote from Apple CEO Tim Cook is all the motivation you need to get up to speed:  

“AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phone”  

 Anderson wholeheartedly agrees, stating “ImagineAR is the most advanced AR platform in the market today and I am excited to launch the company’s sales and marketing initiatives in the UK and Europe.”  

That quote is just the tip of the iceberg.  Watch what Anderson has to say about the “unlimited possibilities of Augmented Reality” and some pretty good hints about whose doors he will be knocking on first …. which is pretty impressive given the fact August is vacation season in Europe 🙂   

If our interview with CEO Alen Paul Silverrstieen and Michael Anderson is any indication, it sounds like the Company’s growth into the UK and Europe is all but assured in 2020 and well beyond.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Else Nutrition $BABY.ca Provides Corporate Update $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 1:02 PM on Thursday, August 6th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020
  • A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner
  • The Company’s Amazon.com store will launch in the coming weeks

VANCOUVER, BC /August 6, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide the following corporate update.

“Our team has been working relentlessly, during an unprecedently difficult time, to bring our product to market. As we get set to launch, we are beyond thrilled to have crossed major hurdles over the past months and weeks – including full scale manufacturing with a U.S. based partner and mobilization of our U.S. supply chain which has culminated in our ability to ship samples of our plant-based formula for toddlers to eager parents across North America,” said Ms. Hamutal Yitzhak, CEO and Co-Founder of Else.

North America Launch

The Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020. A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner. The Company’s Amazon.com store will launch in the coming weeks.

U.S. Manufacturing

The first full-scale commercial manufacturing run of the toddler nutrition powder product was successfully completed by the Company’s U.S. manufacturing partner and packed at a co-packer plant in Nevada.

The terms of the U.S. manufacturing agreement have been negotiated and a formal agreement will be executed upon the receipt of final yield and cost optimization parameters. The next commercial manufacturing run is booked and secured.

FDA Regulatory Pathway

The Company in conjunction with its FDA consulting partner continues to progress on the regulatory pathway for multiple products including an infant formula and new products currently in development for the adult nutrition market.

Health and Happiness International Holdings Limited

The Company’s negotiations with its strategic partner, H&H Global, for distribution rights of the toddler and infant formula in France are advancing well. The parties are studying the target market needs, channels, and regulations, in addition to preparing a launch plan and negotiating the distribution terms. Additionally, discussions regarding distribution in additional markets have also commenced.

Cash and Runway

The company is well capitalized, with approximately CAD$7.0 million in cash, and no short or long-term debt, to fully support its manufacturing and go-to-market plans for the next 12 months.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

VIDEO – Kontrol Energy $KNR.ca Technology Could Detect #COVID19 In Big Buildings Through Real-Time Air Sampling & Alerts $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 10:14 AM on Thursday, August 6th, 2020
kontrol-logo

If Google NEST is the leader in smart home technology, then Kontrol Energy (KNR:CSE) is the small cap equivalent for smart building technology.  More than just lip service, their established Blue Chip customer base includes:

  • Beyond Meat
  • Oxford Properties
  • Brookfield Asset Management
  • Telus
  • Suncor Energy
  • ….. Many More

Moreover, they’ve signed a major deal wth Toyota (Tsusho Canada), targeting 200 plants requiring up to $1 million each in automation retrofits.

CONCLUSION?  When Kontrol Energy says they are entering a 4-week testing phase – with an independent lab – to determine if their technology can detect COVID-19 in the air of big buildings, you need to take the news seriously.  You know who else took it seriously?  The National Research Council, who granted Kontrol $50,000 to conduct the test.  The amount may seem small but that’s because KNR has already done most of the leg work already and is now in the final 4-week testing phase.  

If successful, the implications could be enormous for their Tier-1 client base, as well as, all commercial buildings, government buildings, schools and other big essential locations that need to find a way to start bringing people back.  In short, Kontrol Energy’s BioCloud Analyzer could have a major impact on the North American economy.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

New Age Metals $NAM.ca Appoints New Director $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 8:54 AM on Thursday, August 6th, 2020

August 6, 2020 – Rockport, Canada – New Age Metals Inc. (TSXV:NAM); (OTC:NMTLF); (FSE:P7J) (“NAM” or the “Company”) is pleased to appoint Mr. Chris Berlet to the Board of Directors.

Harry Barr, Chairman & CEO stated; “We are pleased that Chris Berlet agreed to join our Board. I would like to welcome Chris as a new director of the Company. The board and management recognize Chris’s considerable technical and financial experience in the mining industry and believe that he will be an excellent addition to the Company’s Board.”


Click Image To View Full Size

Mr. Berlet is a graduate of Mining Engineering from Queen’s University (Canada) and holds a Diploma in Accounting & Finance from the London School of Economics and Political Science (U.K.). Mr. Berlet is a CFA Charter Holder (USA) and has 30 years of experience in both finance and the mineral industries. Chris is a proprietor of market information URLs & services including: EcologyFunds.com, MineralPrices.com, MineralFunds.com and INTACnews.com. He is a resource project manager and environmental investor. Chris is currently serving as the President & CEO, Director of Canuc Resources, and Stakeholder Gold Corp.

About the River Valley Palladium Project

The details of the updated Mineral Resource Estimate (MRE) and Preliminary Economic Assessment (PEA) were announced in the press release dated August 9, 2019 and are described on NAM’s website. The pit constrained Updated Mineral Resource Estimate formed the basis of the PEA. At a cut-off grade of 0.35 g/t PdEq, the Updated Mineral Resource Estimate contains 2.867 Moz PdEq in the Measured plus Indicated classifications and 1.059 Moz PdEq in the Inferred classification. The PEA is a preliminary report, but it demonstrates that there are potentially positive economics for a large-scale mining open pit operation, with 14 years of Palladium production. Refer to the NAM website (www.newagemetals.com) for details.

Opt-in List

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news.

About NAM

New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America. The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 km from Sudbury, Ontario as well as the Genesis PGM Project in Alaska. The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field, where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. The Company is actively seeking an option/ joint venture partner for its road-accessible Genesis PGM project in Alaska and for our Lithium division in Manitoba.

New Age Metals is a junior resource company on the TSX Venture Exchange, trading symbol NAM, OTCQB: NMTLF; FSE: P7J with 138,854,511 shares issued to date.

Investors are invited to visit the New Age Metals website at www.newagemetals.com where they can review the company and its corporate activities. Any questions or comments can be directed to [email protected] or Harry Barr at [email protected] or Cody Hunt at [email protected] or call 613 659 2773.

Qualified Person

The contents contained herein that relate to Exploration Results or Mineral Resources is based on information compiled, reviewed or prepared by Bill Stone, P.Geo., a consulting geoscientist for New Age Metals. Dr. Stone is the Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the technical content of this news release.

On behalf of the Board of Directors

Harry Barr”

Harry G. Barr

Chairman and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.

Are you an investor in Pharmacielo $PCLO.ca Check out our recent interview with Avicanna $AVCN.ca

Posted by AGORACOM-JC at 5:20 PM on Wednesday, August 5th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • A Full Pipeline Of Pharmaceuticals In Various Stages Of Trials To Address Dermatology, Psychiatry, Neurology, Pain and Oncology
  • 3 Products Already As Far As PHASE 2

White House Fellow (1990-91), Eric Phillips, Joins Binovi Technologies $VISN.ca as a Strategic Advisor $EYPT $KALA

Posted by AGORACOM-JC at 4:16 PM on Wednesday, August 5th, 2020
http://www.smallcapepicenter.com/binovi%20square.png
  • Announced the engagement of 1990-91 White House Fellow, Eric Phillips, as a strategic advisor to assist with the commercialization of the Binovi Product Platform within government installations
  • “We are extremely privileged to have Mr. Phillips join the company in an official Advisory capacity. He has been following our progress and is excited to join the company at a time when he can make great impact. Our recent acquisition of the VIMA Rev ballistic grade strobe technology is a perfect opportunity to leverage his impressive political relationships. He is an incredibly creative and intelligent problem solver and we are a better company with him on our team.” stated Adam Cegielski, Binovi Founder & CEO.

Toronto, New York – August 5, 2020 – Binovi Technologies Corp., (Binovi) (TSXV:VISN) | (OTC:BNVIF) announces the engagement of 1990-91 White House Fellow, Eric Phillips, as a strategic advisor to assist with the commercialization of the Binovi Product Platform within government installations.

“I look forward to bringing my political and regulatory expertise to Binovi Technologies in order to advance the company’s goals in commercializing the Binovi Platform products within a number of areas overseen by the various levels of government. It is imperative to understand the intricacies of these processes when dealing with matters of health and safety.” said Eric Phillips, 1990-91 White House Fellow, Strategic Advisor.

About Eric Phillips 1990-91 WHF, MBA, CTP, BSc. Engineering

A former Advisor on Sustainable Development for the Government of Guyana, and the CEO of the Green Guyana Expo and International Business Summit, Mr. Phillips has served internationally as Chairman of the Board, CEO, MD, VP, COO, Program Director, and Engineer in seven countries. In the USA, he launched his career as the Project Manager at AT&T Bell Laboratories for the $15B FTS2000 integrated telecommunication project which allowed him, among other factors, to successfully compete to become a 1990-91 White House Fellow. Eric was the only Caribbean educated Fellow of the 700 that have been appointed at that time. A recent recipient of the Golden Arrow of Achievement National Award, Mr. Phillips has lectured in the School of Entrepreneurship and Business Innovation (SEBI) at the University of Guyana.

Mr. Phillips holds a BSc in Chemical Engineering from McMaster University and an MBA in Marketing and International Business. He was also selected as one of fourteen fast-tracked MBA-Engineers to spend fourteen months at Stevens Institute of Technology and AT&T Bell Laboratories in the Communications Training Program (CTP) for Telecommunications Engineering.

He is the Chairman of The esseQuibo Group Inc., a consulting firm that advises Guyana Goldfields Inc. (TSX:GUY) which has recently been acquired by Zijin Mining Group Co., Ltd (SSE: 601899) (SEHK: 2899) for $323M CAD. Eric has been the Managing Director of AT&T (NYSE:T) Africa &The Middle East, Vice President of AT&T Network Systems, the Managing Director for AT&T Central Europe (Ukraine) and the Deputy Director for AT&T Globalization in Europe. He was also a Director of ASC Inc. in London, United Kingdom. Politically, Eric was the Co-Founder of the REFORM Group in Guyana and the co-Author of the Guyana 21 Plan, a blueprint for Guyana’s National Development.

Eric spent seven years in South Africa where he was a Director for Africa Union Holdings, a Director for Combination Therapy Medical Solutions and the COO for Safika Holdings Pty. Eric has won many awards including: the AT&T Senior VP Award (1993); the Bell Labs Outstanding Service Award (1990); and the Scientific Achievement Award for Apollo Technologies in 1982. He has been featured on the cover of Business Week International and Black Engineering Magazines. He was nominated for the United States Black Engineer of the Year Award for his work on FTS-2000.

Eric Phillips is an author and charitable leader holding interest in the advancement of global education and sport. In June of 2015, Eric was appointment by FIFA to manage Guyana’s football development.

“We are extremely privileged to have Mr. Phillips join the company in an official Advisory capacity. He has been following our progress and is excited to join the company at a time when he can make great impact. Our recent acquisition of the VIMA Rev ballistic grade strobe technology is a perfect opportunity to leverage his impressive political relationships. He is an incredibly creative and intelligent problem solver and we are a better company with him on our team.” stated Adam Cegielski, Binovi Founder & CEO.

Electrik Dojo Agreement

The Company also announces that it has retained Electrik Dojo for US$60,000 for a term of 30 days. Electrik Dojo has been engaged for advisory services for increasing brand awareness for the Company. Electrik Dojo has been engaged for native advertising and digital marketing services for the Company. Certain services to be provided by Electrik Dojo are anticipated to include ‘investor relations activities’ under the policies of the TSX Venture Exchange and applicable securities laws. The Company will continue to look at strategic consultants to expand awareness of the Company and its activities.

For additional information on the Company, please visit https://www.binovi.com/investor-reports/

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 1,500 locations across 20 countries.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Tania Archer

Head – Global Marketing | Commercialization | Partnerships

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Kontrol $KNR.ca Receives Approval for Government Grant to Accelerate the Development of New #COVID19 Testing Technology $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 9:35 AM on Wednesday, August 5th, 2020
kontrol-logo
  • Announced that it has received approval for an initial government grant of $50,000 from the National Research Council of Canada to accelerate its new Covid-19 testing technology, the Kontrol BioCloud® analyzer
  • Drawing from its extensive industry experience in air emissions and air quality monitoring, Kontrol is developing a new technology designed to detect and alert for COVID-19, in real-time, through rapid on-site air sampling and detection of aerosol and droplet encapsulated viruses in indoor and outdoor environments
  • Kontrol has developed its initial prototype and has commenced lab testing of the detection chamber
  • The lab will spend the next 4 weeks testing the detection chamber and the applicable interactions with COVID-19.

TORONTO, ON /  August 5, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to announce that it has received approval for an initial government grant of $50,000 from the National Research Council of Canada to accelerate its new Covid-19 testing technology, the Kontrol BioCloud® analyzer (“BioCloud analyzer” or “BioCloud”).

Can we measure for COVID-19 like we do for air quality?

Drawing from its extensive industry experience in air emissions and air quality monitoring, Kontrol is developing a new technology designed to detect and alert for COVID-19, in real-time, through rapid on-site air sampling and detection of aerosol and droplet encapsulated viruses in indoor and outdoor environments.

Artist Rendering. Copyright Kontrol Energy Corp.

“Our team has been working to bring BioCloud to market since the onset of COVID-19 and we see a great need for a technology which can provide a level of assurance that spaces where individuals work and congregate can be safe,” says Paul Ghezzi, Chief Executive Officer of Kontrol. “If successful, BioCloud will be able to provide pro-active virus detection capabilities with an alert and notification system in public settings and to help maintain confidence as economies re-open.”

COVID-19 Testing

The current focus of testing for COVID-19 has been individual swabs. While this remains an important part of the testing regime it would not be possible to test all individuals daily in the cases of large gatherings and transportation.

According to the Center for Disease Control, “the virus that causes COVID-19 is thought to spread mainly from person to person, mainly through respiratory droplets produced when an infected person coughs, sneezes, or talks. These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. COVID-19 seems to be spreading easily and sustainably in the community (“community spread”).Community spread means people have been infected with the virus in an area, including some who are not sure how or where they became infected.”

source: www.cdc.gov/coronavirus/2019-ncov/faq.html#Spread


Artist Rendering. Copyright Kontrol Energy Corp.

BioCloud has been designed to operate in open spaces where crowds gather or congregate. Through constant air sampling over designated intervals of time and a propriety detection chamber, designed to interact with COVID-19, BioCloud seeks to provide a real-time detection and alert system. BioCloud’s anticipated applications include schools, buildings, hospitals, transportation, or any location where crowds are gathered.

“When we initiated the design of BioCloud we leveraged our extensive experience in sampling for low level particulate matter in industrial facilities which includes air quality, emissions and various gases,” says Gary Saunders, VP of Kontrol. “We appreciate the government support received to date to accelerate the development of BioCloud.”

Development Plan

Kontrol has developed its initial prototype and has commenced lab testing of the detection chamber. The lab will spend the next 4 weeks testing the detection chamber and the applicable interactions with COVID-19. Following the testing period, Kontrol will announce the results and provide further details on its go to market strategy.

Kontrol is not making any express or implied claims that its BioCloud analyzer has the ability to measure or detect COVID-19 at this time.

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada’s fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean’s.


Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.


For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.